First Time Loading...

Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 5.2194 USD 0.96% Market Closed
Updated: May 3, 2024

Aurinia Pharmaceuticals Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aurinia Pharmaceuticals Inc
Cash from Investing Activities Peer Comparison

Comparables:
ZYME
TH
RPTX
FUSN
EDT

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Cash from Investing Activities
-$6.7m
CAGR 3-Years
65%
CAGR 5-Years
-149%
CAGR 10-Years
-67%
Zymeworks Inc
NYSE:ZYME
Cash from Investing Activities
-$207.3m
CAGR 3-Years
-68%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Cash from Investing Activities
$1.6m
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
-14%
Repare Therapeutics Inc
NASDAQ:RPTX
Cash from Investing Activities
$78m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Cash from Investing Activities
-$42.8m
CAGR 3-Years
41%
CAGR 5-Years
-107%
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Cash from Investing Activities
-CA$185k
CAGR 3-Years
15%
CAGR 5-Years
-30%
CAGR 10-Years
N/A

See Also

What is Aurinia Pharmaceuticals Inc's Cash from Investing Activities?
Cash from Investing Activities
-6.7m USD

Based on the financial report for Dec 31, 2023, Aurinia Pharmaceuticals Inc's Cash from Investing Activities amounts to -6.7m USD.

What is Aurinia Pharmaceuticals Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-67%

Over the last year, the Cash from Investing Activities growth was 89%. The average annual Cash from Investing Activities growth rates for Aurinia Pharmaceuticals Inc have been 65% over the past three years , -149% over the past five years , and -67% over the past ten years .